Oxacyclodotetraconta-3,13,17,21,39-pentaen-2-one,42-(5-amino-2-hydroxy-1-methylpentyl)-8,10,16,20,24,26,28,30,32,34,36,38-dodecahydroxy-23-(a-D-mannopyranosyloxy)-3,7,9,15,19,21,31,33-octamethyl-,(3E,7S,8R,9S,10S,13E,15S,16S,17E,19S,20R,21E,23S,24R,26S,28S,30S,31S,32R,33S,34R,36S,38S,39E,42S)-(9CI),121820-50-6 Products Supply

Name: Oxacyclodotetraconta-3,13,17,21,39-pentaen-2-one,42-(5-amino-2-hydroxy-1-methylpentyl)-8,10,16,20,24,26,28,30,32,34,36,38-dodecahydroxy-23-(a-D-mannopyranosyloxy)-3,7,9,15,19,21,31,33-octamethyl-,(3E,7S,8R,9S,10S,13E,15S,16S,17E,19S,20R,21E,23S,24R,26S,28S,30S,31S,32R,33S,34R,36S,38S,39E,42S)-(9CI)
CAS NO.: 121820-50-6
Synonyms:
DesertomycinA
Molecular Structure:
Molecular Formula: C61H109 N O21

Send a message direct to supplier(s)*

Please post your buying leads,so that our qualified suppliers will soon contact you!

CAS NO.：
* Purchase Request：

* Your Email：
* Name：
* Gender：	Male Female
* Country/Area：
* Company Name：
* Tel：	- - Country - Code Area - Code Number

* Message：

Related products: Oxacyclodotetraconta-3,13,17,2; Oxacyclodotetraconta-3,13,17,2; 1/C33H42O7/c1-19-25-17-24-18-2; 1/C51H74N2/c1-5-9-13-17-21-49(; 1/C28H41N5O15S.Na/c1-12(2)21(2; 1/C27H27N3O3S/c1-30-25(20-11-1; 1/C26H18O2/c1-17-16-23-21-9-5-; 1/C22H28O6/c1-23-17-11-21(27-5; 1/C21H26N2O4/c1-3-14-8-9-19(25; Guanidine,[(4R,5R)-5-[(2S,4E,6; 11',29'-di-tert-butyl-5',17',2; 1/C19H15ClN2O2S/c1-11-19(23)24; 1/C18H18O6/c1-22-14-8-13(20)15; 13H-12,16-Imino-2H,5H-pyrano[3; Spiro[cyclohexane-1,2'-[9,4](e; 1/C17H22N6/c1-2-8-19-13-11-14(; Spiro[cyclopentane-1,2'-[9,4](; 1/C23H22N2O2/c26-23(27-22-15-2; 1/C19H20O5/c1-11(2)7-18(21)24-; (3S,6S,9S,12R,15S,18S,21S,24S,; 1/C18H19NO4/c1-22-15-8-11-10(7; 1/C30H52/c1-10-25(6)16-12-20-3; 1/C19H24N2O2/c1-12(2)14-8-6-9-; 1/C14H13N7O/c1-8-12(21-14(17)1; Oxacyclohexatriaconta-3,5,7,9,; Oxacyclohexatriaconta-3,5,7,9,; 1/C16H14ClNO3/c1-10-6-12(17)7-; 1/C20H20N2/c1-4-10-16(11-5-1)1; Oxacyclodotetraconta-4,22,26,3; 1/C17H16N2O3/c1-9(20)12-8-14-1;